QUADRATEK Trademark

Trademark Overview


On Thursday, March 2, 2023, a trademark application was filed for QUADRATEK with the United States Patent and Trademark Office. The USPTO has given the QUADRATEK trademark a serial number of 79370605. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, March 12, 2024. This trademark is owned by Inmagene Biopharmaceuticals (Hangzhou) Co., Ltd.. The QUADRATEK trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medicines for the treatment and control of inflammation and immune system related diseases; pharmaceutical preparations for inflammation and immune system related diseases; chemical preparations for pharmaceutical or medical purposes, namely, for inflammation and immune system related diseases; biological preparations for the treatment and control of inflammation and immune system related diseases; allergy relief medication; allergy medication

Biotechnology research; biomedical research services; pharmaceutical research services; scientific research and development; research and development of new products for others; scientific laboratory services; quality control for others; quality evaluation services for the medical and anesthesia industries; scientific research and development in the field of immunity and antibody screening; research and development services in the field of antibodies
quadratek

General Information


Serial Number79370605
Word MarkQUADRATEK
Filing DateThursday, March 2, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, March 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2024

Trademark Statements


Goods and ServicesMedicines for the treatment and control of inflammation and immune system related diseases; pharmaceutical preparations for inflammation and immune system related diseases; chemical preparations for pharmaceutical or medical purposes, namely, for inflammation and immune system related diseases; biological preparations for the treatment and control of inflammation and immune system related diseases; allergy relief medication; allergy medication
Goods and ServicesBiotechnology research; biomedical research services; pharmaceutical research services; scientific research and development; research and development of new products for others; scientific laboratory services; quality control for others; quality evaluation services for the medical and anesthesia industries; scientific research and development in the field of immunity and antibody screening; research and development services in the field of antibodies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 1, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameInmagene Biopharmaceuticals (Hangzhou) Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCN

Trademark Events


Event DateEvent Description
Wednesday, March 27, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 27, 2024NOTICE OF PUBLICATION
Wednesday, March 27, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, March 11, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 14, 2024REFUSAL PROCESSED BY IB
Friday, January 19, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 19, 2024REFUSAL PROCESSED BY MPU
Saturday, December 2, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 1, 2023NON-FINAL ACTION WRITTEN
Friday, December 1, 2023ASSIGNED TO EXAMINER
Tuesday, June 6, 2023APPLICATION FILING RECEIPT MAILED
Thursday, June 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 1, 2023LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, May 25, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB